Group 1 - The core viewpoint of the news is that Wen Zhi Traditional Chinese Medicine submitted its Hong Kong IPO prospectus, which will expire after six months, marking the second time the company has faced a submission expiration [1] - The company has established a comprehensive traditional Chinese medicine business layout to meet customer needs ranging from disease treatment to health care and learning [2] - According to a report by Zhi Shi Consulting, Wen Zhi Traditional Chinese Medicine is the largest provider of AI-assisted traditional Chinese medical services in mainland China for 2023 and 2024, with market shares of 1.5% and 1.3% respectively [2] Group 2 - The AI-assisted traditional Chinese medical services market is considered a sub-market, accounting for 1.4% of the overall traditional Chinese medical services market in mainland China in 2024 [2]

Core Viewpoint - The company, Wenzhi Traditional Chinese Medicine, has submitted a listing application to the Hong Kong Stock Exchange, aiming to capitalize on its position as a leading provider of AI-assisted TCM services in mainland China [1] Company Overview - Wenzhi Traditional Chinese Medicine is recognized as the largest provider of AI-assisted TCM medical services in mainland China, holding market shares of 1.5% and 1.3% for the years 2023 and 2024 respectively [1] - The company has developed an AI-assisted diagnostic system called "TCM Brain," which is the first and only TCM AI-assisted diagnostic system validated through clinical consistency studies at a Class III hospital in mainland China [2] Market Characteristics - The TCM medical service industry in mainland China is highly fragmented, with significant potential for development and integration [2] - As of 2024, there are approximately 760,000 licensed TCM practitioners in mainland China, with less than 5% being senior practitioners, indicating a supply-demand imbalance [2] Financial Performance - The company's revenue for the fiscal years 2022, 2023, and 2024 was approximately 62.17 million, 189 million, and 236 million RMB respectively, with losses of approximately 154 million, 194 million, and 45.37 million RMB for the same periods [3] - For the five months ending May 31, 2024, the company reported revenue of approximately 89.84 million RMB and a loss of approximately 2.39 million RMB [3] Community Engagement - Wenzhi Traditional Chinese Medicine has established the Jingyi Academy, which is the largest registered TCM community in mainland China as of May 31, 2025, aimed at promoting TCM culture and enhancing brand awareness [3]